PS-OC News

Drug-chemo combo destroys challenging breast cancer stem cells

Researchers affiliated with Johns Hopkins Physical Sciences-Oncology Center (PS-OC) have shown that combining chemotherapy with an agent that blocks a certain cancer survival protein holds the key to fighting one of the the toughest forms of breast cancer. Only 20 percent of patients with what are known as "triple-negative" breast cancer cells respond to chemotherapy. PS-OC associate director and Johns Hopkins … more

Join Our PS-OC Mailing List

Full Name
Email *